Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Rueil Malmaison, France Clinical Trials

A listing of Rueil Malmaison, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (300) clinical trials

Routine Care Study Evaluating Ocular Torsion

The paralysis of the fourth cranial nerve (paralysis IV), commonly known as the superior oblique muscle (SO) paralysis, represents half of vertical strabismus. The diagnosis of SO paralysis and of its congenital or acquired etiology, are based on a range of clinical findings. The three main clinical diagnostic elements are ...

Phase N/A

9.55 miles

Learn More »

Correlation Between Macular Ischemia and Peripheral Ischemia in Patients With Diabetes

The contribution of OCT- angiography (OCT-A) allows to consider, in a more or less long term, a drastic reduction in the use of fluorescein angiographies in diabetic retinopathy. The accuracy of the analysis of the vascularization of retinal layers of the posterior pole of the eye by the OCT-A , ...

Phase N/A

9.55 miles

Learn More »

Patients' Follow-up After Subarachnoid Haemorrhage Caused by Ruptured Intracranial Aneurysms

After endovascular treatment of the intracranial aneurysm, recanalization may occur, with a risk of recurrent subarachnoid haemorrhage or long-term angiographic recurrences of aneurysms. Few data exist on patients' long-term follow-up after subarachnoid haemorrhage caused by ruptured intracranial aneurysms.

Phase N/A

9.55 miles

Learn More »

Impact of Neutrophil Activation in Acute Ischemic Stroke Patients Treated With Endovascular Therapy

Clinical and experimental data suggest that neutrophil activation and extravasation are deleterious in acute ischemic stroke (AIS) involving an increased risk of unfavorable outcome and hemorrhagic transformation (HT). However, clinical trials targeting neutrophil recruitment in AIS patients were negative. Recently, an experimental study has shown that neutrophil activation and transmigration ...

Phase N/A

9.55 miles

Learn More »

Impact of Platelet Activation in Intracranial Aneurysm Rupture Risk - PLAQRAN

Sub arachnoid hemorrhage consecutive to intracranial aneurysm rupture is a devastating disease. Predictors of intracranial aneurysm rupture are limited and focus mainly on size and location. Platelet activation may have a deleterious role on aneurysm rupture. The assumption is that patients with ruptured intracranial aneurysm will present a higher rate ...

Phase N/A

9.55 miles

Learn More »

CLARYS: CLinical Assessment of WEB Device in Ruptured aneurYSms

All eligible subjects presenting to the participating Registry Center will be considered for entry into the Registry. Up to 70 evaluable subjects meeting the Registry entry criteria will be enrolled. An intermediary analysis will be performed when the first forty (40) subjects reaching the planned one month follow-up. subjects will ...

Phase N/A

9.58 miles

Learn More »

The PAH Disability and Bothersomeness Questionnaire

A 3-steps study protocol was initiated in 2011 to develop a patient reported outcome measure (PROM) in PAH.The first two steps have been completed (qualitative study and Delphi consensus study) leading to the development of a provisional 37-items questionnaire. A reduction of items in this provisional questionnaire and the validation ...

Phase N/A

9.58 miles

Learn More »

French National Registry: ART REGISTRY (Observational Study)

Design: Observational, multicentre, longitudinal, prospective registry Primary objective: To evaluate the real life efficacy and safety of anti-TNF inhibitors in patients with RA using a prospective national registry. Target population: Patients initiating anti-TNF therapy for RA (including infliximab, adalimumab, etanercept, certolizumab and golimumab, and their respective biosimilar according to their ...

Phase N/A

9.58 miles

Learn More »

The ASSESS National Multi-center Prospective Cohort

Primary Sjgren's syndrome (pSS) affects 0,1% of the population. This systemic autoimmune disease is characterized by disabling dryness, fatigue and pain, and systemic complications in 30% of patients. No treatment has proven effective in this disease. The previous or present systemic complications included skin, articular, lung, kidney, peripheral and central ...

Phase N/A

9.58 miles

Learn More »

Exploration of Dyspnea at Non-high Brain Natriuretic Peptide (BNP)

Patients with unexplained stress dyspnea ( stage 2 NYHA), no significant underlying lung disease, with an ejection fraction > 50%, normal resting filling pressures, NTproBNP < 220 pg/ml in < 75 years, and < 450 pg/ml in 75 years will be studied with stress echocardiography and cardiometabolic stress test (VO2). ...

Phase N/A

9.58 miles

Learn More »